NET LOSS PER SHARE

9 Months Ended

Sep. 30, 2024

Basic and diluted net loss per share attributable to common stockholders are calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Net loss	$	(992,475)	$	(630,894)	$	(2,316,724)	$	(2,174,654)
Accretion of redeemable convertible preferred stock (related party)	42,838		—		(107,924)		—
Net loss attributable to common stockholders, basic and diluted	$	(949,637)	$	(630,894)	$	(2,424,648)	$	(2,174,654)

Weighted-average shares outstanding attributable to common stockholders, basic and diluted	2,323,971,541		2,284,446,783		2,312,249,333		2,010,916,100

Net loss per share attributable to common stockholders, basic and diluted	$	(0.41)	$	(0.28)	$	(1.05)	$	(1.08)

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:


	September 30,
Excluded Securities	2024	2023
Private Placement Warrants to purchase common stock	44,350,000	44,350,000
Options outstanding to purchase common stock	28,845,241	34,320,337
RSUs outstanding	101,501,380	51,817,847
Employee stock purchase plan	16,831,978	9,353,757
If-converted common shares from convertible note	36,737,785	36,737,785
If-converted common shares from Series A redeemable convertible preferred stock	291,019,450	—
If-converted common shares from Series B redeemable convertible preferred stock	173,206,009	—
Total	692,491,843	176,579,726

The 14,673,053 and 9,452,483 shares of common stock equivalents subject to RSUs are excluded from the anti-dilutive table above as the underlying shares remain contingently issuable since the respective performance conditions have not been satisfied as of September 30, 2024 and 2023, respectively.